PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, University of Arizona Health Sciences, Tucson, AZ, USA.\', \'Department of Radiation Oncology, University of Arizona Health Sciences, Tucson, AZ, USA.\', \'Department of Cellular and Molecular Medicine, University of Arizona Health Sciences, Tucson, AZ, USA.\', \'Department of Medicine, Indiana University, Indianapolis, IN, USA.\', \'Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.\', \'Institute of Surgical Research, San Antonio, TX, USA.\', \'College of Pharmacy, University of Arizona Health Sciences, Tucson, AZ, USA.\', \'Department of Medicine, University of Arizona Health Sciences, Tucson, AZ, USA. skipgarcia@email.arizona.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-04444-9
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35027578
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • eNAMPT neutralization reduces preclinical ARDS severity via rectified NFkB and Akt/mTORC2 signaling.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35027578>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35027578>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all